LUMINACCURACY

Increased sensitivity of detection enables earlier detection. At Luminaccuracy they utilize a novel technology that allows up to 1000 times increased sensitivity to detect low levels of markers present in the early stages of disease compared to conventional assays via a mechanism that is minimally invasive. They are developing a rapid and sensitive test for early detection of the C. diff infection. Their technology is tunable, multiplex and versatile. They foresee applications in a wide variety of diseases.